alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 331.16 Transfers. ( a ) Except as provided in paragraph (c) of this section, a select agent or toxin may only be transferred to an individual or entity registered to possess, use, or transfer that agent or toxin. A select agent or toxin may only be transferred under the conditions of this section and must be authorized by APHIS or CDC prior to the transfer.[7]
( b ) A transfer may be authorized if: ( 1 ) The sender: ( i ) Has at the time of transfer a certificate of registration that covers the particular select agent or toxin to be transferred and meets all the requirements of this part;
( ii ) Meets the exemption requirements for the particular select agent or toxin to be transferred; or
( iii ) Is transferring the select agent or toxin from outside of the United States and meets all import requirements.
( 2 ) At the time of transfer, the recipient has a certificate of registration that includes the particular select agent or toxin to be transferred and meets all of the requirements of this part.
( c ) On a case-by-case basis, the Administrator may authorize a transfer of a select agent or toxin not otherwise eligible for transfer under this part under conditions prescribed by the Administrator.
( d ) To obtain authorization for a transfer, APHIS/CDC Form 2 must be submitted.
( e ) After authorization is provided by APHIS or CDC, the packaging of the select agent(s) and toxin(s) is performed by an individual approved by the HHS Secretary or Administrator to have access to select agents and toxins and is in compliance with all applicable laws concerning packaging.
( f ) The sender must comply with all applicable laws governing shipping.
( g ) Transportation in commerce starts when the select agent(s) or toxin(s) are packaged for shipment and ready for receipt by a courier transporting select agent(s) or toxin(s) and ends when the package is received by the intended recipient who is an individual approved by the HHS Secretary or Administrator to have access to select agents and toxins, following a security risk assessment by the Attorney General.
( h ) The recipient must submit a completed APHIS/CDC Form 2 within 2 business days of receipt of a select agent or toxin.
( i ) The recipient must immediately notify APHIS or CDC if the select agent or toxin has not been received within 48 hours after the expected delivery time or if the package containing the select agent or toxin has been damaged to the extent that a release of the select agent or toxin may have occurred.
( j ) An authorization for a transfer shall be valid only for 30 calendar days after issuance, except that such an authorization becomes immediately null and void if any facts supporting the authorization change (*e.g.*, change in the certificate of registration for the sender or recipient, change in the application for transfer).
[70 FR 13278, Mar. 18, 2005, as amended at 77 FR 61077, Oct. 5, 2012; 82 FR 6206, Jan. 19, 2017] Footnotes -
331.16
[7] The requirements of this section do not apply to transfers within a registered entity (*i.e.*, the sender and the recipient are covered by the same certificate of registration).
#### § 500.21 Fee schedule for tram and tours.

The USNA provides tours of the USNA grounds in a 48-passenger tram (accommodating 2 wheelchairs). The fee is as follows: $4.00 per adult, $3.00 per senior citizen or Friend of the National Arboretum, and $2.00 per child under the age 17. Children under 4 sharing a seat with an adult will not be charged. Pre-scheduled tram tours for groups may be arranged for a set fee of $125.00. Additionally, a tour guide may be pre-arranged to provide a non-tram tour for the fee of $50 per hour. Promotional programs offering discounted fees for these programs may be instituted at the discretion of the USNA. Payment for use of the tram is due at the time of ticket purchase. Payment for pre-scheduled tram tours must be made at least one week in advance. Payment for pre-scheduled, non-tram guided tours must be made at least one week in advance of the tour date.
23.601 Requirements.

(a) The clause at 52.223-7, Notice of Radioactive Materials, requires the contractor to notify the

contracting officer prior to delivery of radioactive material.

(b) Upon receipt of the notice, the contracting officer shall notify receiving activities so that

appropriate safeguards can be taken.

(c) The clause permits the contracting officer to waive the notification if the contractor states that

the notification on prior deliveries is still current. The contracting officer may waive the notice only

after consultation with cognizant technical representatives.

(d) The contracting officer is required to specify in the clause at 52.223-7, the number of days in

advance of delivery that the contractor will provide notification. The determination of the number of

days should be done in coordination with the installation/facility radiation protection officer (RPO).

The RPO is responsible for insuring the proper license, authorization or permit is obtained prior to

receipt of the radioactive material.

Parent topic: Subpart 23.6 - Notice of Radioactive Material
Part 20 - Reserved           **Parent topic:** Federal Acquisition Regulation
#### In the Matter of Toshiko Becker, Respondent, v Richard Becker, Appellant.

In a support proceeding, the husband appeals from so much of an order of the Family Court, Nassau County, entered January 29, 1979, as found that he had willfully disobeyed a support order of the same court, committed him to jail for 30 days, and fixed the amount of arrears due to the petitioner wife and to the Nassau County Department of Social Services at $4,401 and $3,517, respectively. Order reversed, insofar as appealed from, on the law, without costs or disbursements, and matter remitted to the Family Court, Nassau County, for a further hearing to determine the issues of (a) the petitioner’s reasons for removing the child of the parties to California, and (b) the appellant’s financial ability to pay support from June 13, 1972 to February 4, 1976. Absent exceptional reasons therefor, the petitioner’s removal of the parties’ child to a community 3,000 miles from the appellant father unjustifiably denied him his right of visitation as provided in the order dated April 23, 1975 (see *Strahl v Strahl,*66 AD2d 571, 578-579). Since the record is silent as to the petitioner’s reasons for such removal, a hearing should be had with respect thereto (see *Abraham v Abraham,*44 AD2d 675, 676), and with respect to appellant’s financial ability to pay support from June 13, 1972 to February 4, 1976 (the trial court improperly refused to accept testimony pertaining to appellant’s financial ability). Mollen, P. J., Gibbons, Martuscello and Weinstein, JJ., concur.
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[S. 2406 Introduced in Senate (IS)]

109th CONGRESS
  2d Session
                                S. 2406

          To suspend temporarily the duty on 1,2-Pentanediol.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             March 13, 2006

  Mr. DeMint introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
          To suspend temporarily the duty on 1,2-Pentanediol.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. 1,2-PENTANEDIOL.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following:

``      9902.34.33       1,2-Pentanediol    Free         No change        No change        On or before 12/  ''.
                         (CAS No. 5343-92-                                                  31/2009
                         0) (provided for
                         in subheading
                         2905.39.90)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
EXHIBIT 32.1




CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned hereby certifies that, to his knowledge, the annual report on Form 10-K (the "Report") of ANTs software inc., a Delaware corporation (the "Company"), for the year ended December 31, 2009:




1. Fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and




2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.




This certification is being provided pursuant to 18 U.S.C. 1350 and is not to be deemed a part of this Report, nor is it to be deemed to be "filed" for any purpose whatsoever.




Date:  March 31, 2010
/s/ Joseph Kozak

Joseph Kozak, Chairman, Chief ExecutiveOfficer and President




A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company, and will be retained by the Company, and furnished to the Securities and Exchange Commission upon request.
2006-0568.

#### State v. Taylor.

Montgomery App. No. 20649. This cause is pending before the court on the certification of a conflict by the Court of Appeals for Montgomery County. It appearing to the court that appellant is without counsel,

IT IS ORDERED by the court that Charles M. Miller of Cincinnati, Ohio, is appointed to represent appellant on a pro bono basis.
CERTIFICATIONI, Kokmeng Koh, certify that: 1. I have reviewed this report on Form 10-K and all reports on Form 10-Drequired to be filed in respect of the period covered by this report on Form 10-K ofPrincipal Life Income Fundings Trust 2006-53 (the “Exchange Act periodic reports”);  2. Based on my knowledge, the Exchange Act periodic reports, taken as whole, donot contain any untrue statement of a material fact or omit to state a material factnecessary to make the statements made, in light of the circumstances under which suchstatements were made, not misleading with respect to the period covered by thisreport;  3. Based on my knowledge, all of the distribution, servicing and otherinformation required to be provided under Form 10-D for the period covered by thisreport is included in the Exchange Act periodic reports;  4. Based on my knowledge and the servicer compliance statement(s) required inthis report under Item 1123 of Regulation AB, and except as disclosed in the ExchangeAct period reports, the servicer has fulfilled its obligations under the servicingagreement(s) in all material respects; and  5. All of the reports on assessment of compliance with servicing criteria forasset-backed securities and their related attestation reports on assessment ofcompliance with servicing criteria for asset-backed securities required to be includedin this report in accordance with Item 1122 of Regulation AB and Exchange Act Rules13a-18 and 15d-18 have been included as an exhibit to this report, except as otherwisedisclosed in this report. Any material instances of noncompliance described in suchreports have been disclosed in this report on Form 10-K.In giving the certifications above, I have reasonably relied on information provided to me by thefollowing unaffiliated parties: Citibank, N.A. and Bankers Trust Company, N.A.Date: March 28, 2007   /s/ Kokmeng Koh     Kokmeng Koh  Second Vice President
<PAGE>

                        INDEPENDENT AUDITORS' CONSENT

The Board of Directors and Stockholders
First Brands Corporation:

We consent to incorporation by reference in the Registration Statement No.
333-25773 on Form S-4 and Nos. 33-35770, 33-56992, 33-56503, 333-20949 and
333-45379 on Form S-8 of First Brands Corporation of our report dated August 6,
1998, relating to the consolidated balance sheets of First Brands Corporation
and subsidiaries as of June 30, 1998 and 1997, and the related consolidated
statements of income, stockholders' equity, and cash flows for each of the
years in the three-year period ended June 30, 1998, which report refers to a
change in the method of accounting for business process re-engineering costs,
and our report dated August 6, 1998 on the related schedule, which reports
respectively are incorporated by reference and appear in the June 30, 1998
annual report on Form 10-K of First Brands Corporation.


                                            /s/ KPMG Peat Marwick LLP
                                            KPMG Peat Marwick LLP

New York, New York
September 22, 1998

<PAGE>
Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of SkyTerra Communications, Inc. (the
Company) for the period ended September 30, 2007 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Alexander H. Good, Chief Executive Officer and President of the Company, hereby
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                                     
|-------------------------------------
|/s/ Alexander H. Good                
|Alexander H. Good                    
|Chief Executive Officer and President

November 9, 2007
[Federal Register Volume 75, Number 27 (Wednesday, February 10, 2010)]
[Notices]
[Page 6637]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-2940]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

National Oceanic and Atmospheric Administration


National Sea Grant Advisory Board

AGENCY: National Oceanic and Atmospheric Administration, Commerce.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: This notice sets forth the schedule and proposed agenda of a 
forthcoming meeting of the Sea Grant Advisory Board (Board). Board 
members will discuss and provide advice on the National Sea Grant 
College Program in the areas of program evaluation, strategic planning, 
education and extension, science and technology programs, and other 
matters as described in the Agenda below.

DATES: The announced meeting is scheduled for Tuesday March 9--
Wednesday March 10, 2010.

ADDRESSES: The meeting will be held at the Washington Plaza Hotel, 10 
Thomas Circle Northwest, Washington, DC.

FOR FURTHER INFORMATION CONTACT: Ms. Ann Andrus, National Sea Grant 
College Program, National Oceanic and Atmospheric Administration, 1315 
East-West Highway, Room 11704, Silver Spring, Maryland 20910, 301-734-
1088.

SUPPLEMENTARY INFORMATION: The Board, which consists of a balanced 
representation from academia, industry, state government and citizens 
groups, was established by Section 209 of the Sea Grant Program 
Improvement Act of 1976 (Pub. L. 94-461, 33 U.S.C. 1128). The duties of 
the Board were amended by the National Sea Grant College Program 
Amendments Act of 2008 (Pub. L. 110-394). The Board advises the 
Secretary of Commerce and the Director of the National Sea Grant 
College Program with respect to operations under the Act, and such 
other matters as the Secretary refers to them for review and advice.
    The agenda for the meeting can be found at http://www.seagrant.noaa.gov/leadership/advisoryboard/agenda_0310.pdf.

    Dated: February 4, 2010.
Mark E. Brown,
Chief Financial Officer/Chief Administrator Officer, Office of Oceanic 
and Atmospheric Research, National Oceanic and Atmospheric 
Administration.
[FR Doc. 2010-2940 Filed 2-9-10; 8:45 am]
BILLING CODE 3510-KA-P
[Federal Register Volume 75, Number 228 (Monday, November 29, 2010)]
[Notices]
[Page 73115]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-29947]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel, Program Project: Grant in Cell Biology.
    Date: December 16-17, 2010.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892. (Virtual Meeting).
    Contact Person: David Balasundaram, PhD, Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5189, MSC 7840, Bethesda, MD 
20892. 301-435-1022. <a href="/cdn-cgi/l/email-protection#0d6f6c616c7e7863696c7f6c60694d6e7e7f23636465236a627b"><span class="__cf_email__" data-cfemail="c9aba8a5a8babca7ada8bba8a4ad89aababbe7a7a0a1e7aea6bf">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: November 19, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-29947 Filed 11-26-10; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
exv10w20






Exhibit 10.20




2009 Corporate Bonus Plan Summary




     The following is a summary of key terms of SuccessFactors’ 2009 Corporate Bonus Plan. This
plan does not cover personnel under sales commission or other commission-based plans.



     The total bonus pool under the plan for 2009 would be based on achievement of various
performance targets. 50% of the total bonus pool would be funded based on achievement of
performance targets based on bookings, operating cash flow and renewals. These performance targets
would vary on a sliding scale basis, corresponding to payout multipliers ranging from 75% to 130%
of the target payout.



     The remaining 50% of the total bonus pool would be funded based on achievement of quarterly
performance targets based on bookings and cash flow, with 12.5% of the total bonus pool being the
target payout for each quarter. These quarterly performance targets would vary on a sliding scale
basis, corresponding to payout multipliers ranging from 80% to 130% of the target payout.



     Any bonus would be paid after the completion of the year. Employees must be employed at the
time of payment to be entitled to receive a bonus payment. Notwithstanding the plan, the total
bonus pool amount may be adjusted by the Compensation Committee or the Board of Directors in their
sole discretion. Any determination of performance, payment or other matter under this plan by the
Compensation Committee or the Board of Directors is binding. Individual bonus amounts are the
responsibility of Company management. With respect to executive officers of the Company, the CEO
shall recommend individual bonus amounts for approval by the Compensation Committee.



     Except as otherwise provided in an individual employment agreement or by applicable law in the
relevant jurisdiction: (i) participation in this plan is not an agreement (express or implied)
between the plan participant and SuccessFactors that the participant will be employed for any
specific period of time, nor is there any agreement for continuing or long-term employment; (ii)
the plan participant and SuccessFactors each have the right to terminate the employment
relationship at any time for any reason; and (iii) this at-will employment relationship can only be
modified by an agreement signed by the participant and SuccessFactors.



     This summary highlights the principal features of the SuccessFactors 2009 Corporate Bonus Plan
but does not describe every situation that can occur. The Compensation Committee and Board of
Directors retain the right to interpret, revise, modify or delete the plan at their sole discretion
at any time.



     This plan is intended to be effective for at least fiscal year 2009 and shall remain in effect
until amended or terminated by the Compensation Committee or Board of Directors.